Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,942
datasets available to search
ShareScore release 0.9.0
Dataset results
8,942 results for “Prostate”
Underlying data for Comparing Monotherapy with Tadalafil or Tamsulosin Therapy in Men with Benign Prostatic Hyperplasia: a case-control study
<p>Underlying Data for Comparing Monotherapy with Tadalafil or Tamsulosin Therapy in Men with Benign Prostatic Hyperplasia: a case-control study</p>
PROMISE12: Data from the MICCAI Grand Challenge: Prostate MR Image Segmentation 2012
<p>This repository contains all data associated with the 'Prostate MR Image Segmentation'-challenge 2012 on https://promise12.grand-challenge.org/. The goal of this challenge was to compare interactive and (semi)-automatic segmentation algorithms for MRI of the prostate. </p> <p> </p>
Fig. 6 in Bioactive constituents from the leaves of Metapanax delavayi with anti-benign prostatic hyperplasia activities
Fig. 6. Molecular docking simulations obtained at the lowest energy conformation, highlighting potential hydrogen contacts of compound 1 with 5α-reductase (A) and COX-2 (B) proteins and finasteride with 5α-reductase (C) and COX-2 (D) proteins. (Coloured by atom: carbon is cyan; nitrogen is blue; oxygen is red; hydrogen is grey; sulfur is orange). For clarity, only interacting residues are labelled. Hydrogen bonding interactions are shown by dashes. These figures were created by PyMOL. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 5 in Bioactive constituents from the leaves of Metapanax delavayi with anti-benign prostatic hyperplasia activities
Fig. 5. The inhibitory effect of compounds 1–12 on the growth of BPH-1 cells (n = 3). *p <0.05, **p <0.01, and ***p <0.001 compared with 50 μM group; Finasteride was used as positive control.
Fig. 4 in Bioactive constituents from the leaves of Metapanax delavayi with anti-benign prostatic hyperplasia activities
Fig. 4. Calculated and experimental ECD spectra of compounds 1 (A), 2 (B), 4 (C), and 5 (D) in MeOH.
Fig. 2 in Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells
Fig. 2. COSY (in green) and key HMBC (in red) correlations of compound 2. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 4 in Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells
Fig. 4. Effects of compounds 1–9 on cell viability and leucine uptake in LNCaP cells (a) MTT cell growth assay was performed in LNCaP cells treated with compounds 1–9 at 20 μM for 72 h (n = 3, mean ± SEM) (b) [3H]-L-leucine uptake was performed using 20 μM of compounds 1–9 in LNCaP cells (n = 3, mean ± SEM). Asterisks represent Pvalues: *P ⩽ 0.05; ***P ⩽ 0.001 for one-way analysis of variance by Dunnett's multiple comparison test (c) [3H]-L-leucine uptake was performed at varying doses of compounds 4 and 5 to determine the IC50 values (n = 3, mean ± SEM).
Fig. 3 in Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells
Fig. 3. ORTEP of bilocularin A carbamate analogue 7; Hydrogen atoms, EtOH and H2O molecules are omitted for clarity.
Fig. 1. Derivatisation reaction conditions for bilocularin A in Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells
Fig. 1. Derivatisation reaction conditions for bilocularin A (1) and the resulting semi-synthetic carbamate library (2–9).
1H-NMR-based urine metabolomics of prostate cancer and benign prostatic hyperplasia
<p>This dataset was collected from patients diagnosed with prostate cancer (R-sample_number) and benign prostatic hyperplasia (T-sample_number) using 1H-NMR spectroscopy.</p> <p>For more details check our paper: https://doi.org/10.1016/j.heliyon.2024.e28949</p>
Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men
ClinicalTrials.gov study NCT04108871. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT04862091. IPD Sharing: Not stated. Countries: 1. Publications: 1.
SBRT for Oligometastatic Castration-Refractory Prostate Cancer
ClinicalTrials.gov study NCT02816983. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy Study of Acupuncture to Relieve Symptoms of Chronic Prostatitis
ClinicalTrials.gov study NCT00260637. IPD Sharing: Not stated. Countries: 1. Publications: 2.
S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
ClinicalTrials.gov study NCT00030901. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer
ClinicalTrials.gov study NCT05224869. IPD Sharing: NO. Countries: 1. Publications: 1.
Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists
ClinicalTrials.gov study NCT01366053. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer
ClinicalTrials.gov study NCT05249712. IPD Sharing: Not stated. Countries: 1. Publications: 1.
68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks
ClinicalTrials.gov study NCT03604757. IPD Sharing: NO. Countries: 1. Publications: 0.
GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer
ClinicalTrials.gov study NCT00087165. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.